Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pacritinib
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: PERSIST-2 (PAC326), NCI-2014-00893, NCT02055781
Pacritinib and Erlotinib Hydrochloride in Treating Patients with Metastatic or Locally Advanced Non-small Cell Lung Cancer after EGFR TKI Treatment
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201503052, NCI-2015-00399, NCT02342353
Pacritinib in Treating Patients with Metastatic Refractory Colorectal Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 201412087, NCI-2014-02603, 14-x329, NCT02277093
Pacritinib before Chemotherapy and Donor Stem Cell Transplant in Treating Patients with Myeloproliferative Neoplasms
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: 2014-0786, NCI-2015-01123, NCT02410551
Pacritinib and Chemotherapy in Treating Patients with Acute Myeloid Leukemia and FLT3 Mutations
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-14169, NCI-2014-02436, NCT02323607
Start Over